For more information, visit our Interventional Pulmonary - Chest Disease Center Program
Return to Non-Cancer Program Name Search
Title: Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung – Study 3
Brief Title: BREATHE - 3
Brief Summary:
For info regarding 2025P000295
please contact Adnan Majid at 617-632-8252 or
amajid@bidmc.harvard.edu
Title: Evaluating the Efficacy and Safety of Saline Irrigation as an Add-On Therapy for Retained Pleural Infections (LYTICS +)
Brief Title: LYTICS +
Brief Summary: The purpose of this protocol is to conduct a pilot prospective non-blind clinical trial
to evaluate the efficacy and safety of a novel saline irrigation technique as an adjunct
to standard interventions for treating retained pleural infections. Intrapleural
fibrinolytic therapy (IPFT) is commonly used for infections not adequately managed with
antibiotics and intercostal tube drainage, while saline irrigation serves as an
alternative for cases with a high bleeding risk where IPFT is not feasible. The efficacy
of saline irrigation combined with IPFT remains unexplored. The hypothesis is that saline
irrigation could be an effective and safe addition to IPFT for patients with persistent
pleural infections.
The specific aims of the study include:
Determine the efficacy of saline irrigation as add-on therapy to IPFT: Compare the
clinical outcomes of patients receiving saline irrigation combined with IPFT to those
receiving IPFT alone to determine if the addition of saline irrigation offers significant
benefits. Outcomes include changes in inflammatory markers, imaging characteristics
(echography and CT), volume of pleural fluid drained, chest tube duration, hospital
length of stay, and the need for subsequent surgical intervention.
Assess the safety and tolerability of saline irrigation plus IPFT: Compare complications
and patient comfort in those receiving saline irrigation combined with IPFT to those
receiving IPFT alone.
For info regarding 2024P001043
please contact Adnan Majid at 617-632-8252 or
amajid@bidmc.harvard.edu
Title: Spray Cryotherapy for the Management of Benign Central Airway Stenosis (Cryo-BAS): A Multi-Center Randomized Controlled Trial
Brief Title: Cryo-BAS
Brief Summary: The goal of this clinical trial is to compare spray cryotherapy plus balloon dilatation
versus current standard of Care (SoC - steroid injection, radial cuts and balloon
dilatation) in patients with benign airway stenosis with simple stenosis. The main
question[s] investigators aim to answer are:
1. What is the need for reintervention and time to reintervention in participants with
benign airway stenosis with simple stenosis who receive spray cryotherapy plus
balloon dilatation versus standard of care alone?
2. To evaluate patient experience, physiological, anatomical changes, health care
utilization and safety of the SCT plus balloon dilatation versus standard of care
alone.
Researchers will compare spray cryotherapy plus balloon dilatation versus current
standard of Care (SoC - steroid injection, radial cuts and balloon dilatation) in
patients with benign airway stenosis with simple stenosis to see if it reduces the need
of re intervention.
Participants will surgery and receive one of the two interventions.
For info regarding 2024P000875
please contact Adnan Majid at 617-632-8252 or
amajid@bidmc.harvard.edu
Title: A Pilot Assessment of the Safety and Efficacy of Pleural Irrigation for Retained Pleural Infection Using a Novel Irrigation Device
Brief Title: Pleural Irrigation
Brief Summary: Single-arm pilot trial of the use of intrapleural saline irrigation to treat retained
pleural infections for patients with contraindications to standard of care intrapleural
enzymatic therapy.
For info regarding 2024P000822
please contact Adnan Majid at 617-632-8252 or
amajid@bidmc.harvard.edu
Title: An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients with Severe Emphysema: The CONVERT II Trial
Brief Title: CONVERT II
Brief Summary: This is a prospective, open-label, multi-center, single-arm study planned to enroll 200
subjects with heterogeneous emphysema and collateral ventilation (CV) in the target lobe.
Subjects will undergo instillation of AeriSeal Foam in the target lobe and subsequent
assessment of CV status using Chartis Pulmonary Assessment System. Subjects with CV-
status will then undergo placement of Zephyr Valve in the target lobe for bronchoscopic
lung volume reduction (BLVR) and be followed for 24 months.
For info regarding 2024P000635
please contact Adnan Majid at 617-632-8252 or
amajid@bidmc.harvard.edu
Title: Implementation of Low-Cost Single-Use Flexible Bronchoscopes for Routine Interventional Pulmonary Procedures: A Feasibility Study
Brief Title: Vathin Human
Brief Summary: The goal of this pilot single-arm crossover trial is to investigate the feasibility and
safety of using single-use flexible bronchoscopes (SUFB) for routine diagnostic and
therapeutic interventional pulmonary procedures instead of reusable flexible
bronchoscopes (RFB). The main questions it aims to answer are:
Was a decision to crossover from SUFB to RFB (at the discretion of the clinical
bronchoscopist) made ?
Bronchoscopist's assessment of the SUFB for each procedure (using a Likert scale 0-10)
including:
1. Overall assessment
2. Scope quality
3. Scope handling
4. Scope maneuverability
5. Tool compatibility
6. Suction
7. Lavage
8. Safety
9. Image quality
Participants will undergo bronchoscopy with single use bronchoscopes.
For info regarding 2024P000471
please contact Adnan Majid at 617-632-8252 or
amajid@bidmc.harvard.edu
Title: Inter-lobar Fissure Completion as a Salvage Treatment in Patients with Failed Lung Volume Reduction (SAVED-1)
Brief Title: Rescue lung fissure closure after failed EBV therapy in COPD
Brief Summary: The purpose of this protocol is to perform a pilot prospective controlled clinical trial
to evaluate the potential role of lung fissure completion with pleural adhesiolysis
strategy (experimental intervention) in severe emphysema/COPD patients with failed
bronchoscopic lung volume reduction (BLVR) via the use of endobronchial valves (EBVs)
therapy. In select patients, the lung fissure completion with adhesiolysis strategy will
be performed by video-assisted thoracoscopic surgery (VATS) guided stapling along the
lung fissures to reduce collateral ventilation with adhesions removal and determine
whether this experimental strategy will improve outcomes after failed BLVR in patients
with severe emphysema/COPD.
For info regarding 2022P000048
please contact Adnan Majid at 617-632-8252 or
amajid@bidmc.harvard.edu
Title: The Spiration Valve System (SVS) Post-Market Registry Study for Severe Emphysema
Brief Title: STRIVE SVS Registry Trial
Brief Summary: This is a single-arm, prospective, multi-center, Registry study to evaluate the long-term
safety and effectiveness of the Spiration Valve System (SVS) for the treatment of severe
emphysema in a post-market setting.
For info regarding 2021P001015
please contact Adnan Majid at 617-632-8252 or
TSIPResearchStaff@bidmc.harvard.edu
Title: Combined Zephyr Valve System with Inter-lobar Fissure Completion for Lung Volume Reduction in Emphysema: A Pilot Randomized Controlled Trial
Brief Title: COMPLETE-1
Brief Summary: The purpose of this protocol is to perform a pilot prospective randomized controlled
clinical trial to evaluate the potential role of lung fissure completion strategy
(experimental intervention) in addition to endobronchial valve (EBV) placement
(representing "standard-of-care") in select patients with severe COPD/emphysema and with
evidence for <95% fissure completion between adjacent lung lobes. In select patients,
lung fissure completion strategy will be performed by either video-assisted thorascopic
surgery (VATS)-guided or robotic-guided stapling along the lung fissures in an attempt to
reduce collateral ventilation and determine whether or not this experimental strategy
will improve outcome following subsequent EBV placement. EBV placement will follow
successful VATS-guided or robotic-guided fissure stapling.
The study will enroll approximately 20 patients at BIDMC, and outcomes will focus on
procedure-related complications, physiological measurements (ex., FEV1 by pulmonary
function testing) and clinical symptoms (i.e., questionnaires). Patient will be followed
for 3-month period, receiving usual standard of care during the 3 months of follow-up.
The goal of this protocol is to determine if elimination of significant collateral lung
ventilation between lung lobes is possible, and whether such strategy to eliminate
collateral lung ventilation between lobes improves outcomes following subsequent EBV
placement (i.e. promotes atelectasis of diseased lung segments) in the management of
severe COPD/emphysema in appropriate candidates. For subjects in the medical management
control group, upon completion of the 3-month F/U period, they will be eligible for EBV
if they choose.
For info regarding 2021P000049
please contact Christine Conley at 617-632-8386 or
cconley@bidmc.harvard.edu
Title: Effect of Continuous Positive Airway Pressure (CPAP) on 6-Minute Walk Test Outcomes in Patients With Excessive Central Airway Collapse (ECAC)
Brief Title: Effect of CPAP on 6MWT in Patients with ECAC
Brief Summary: The purpose of this protocol is to perform a prospective, randomized, double-blinded,
pacebo-controlled clinical trial to determine the influence of a non-invasive positive
pressure ventilation device on exercise capacity and symptoms in adult patients with
ECAC. Primary outcome will include the total distance traversed by the study subject
during a standard 6-minute walk test, and secondary outcomes will include peak flow
measurement and symptom reporting before and after the exercise testing. The study will
focus on the use of continuous positive airway pressure (CPAP) device. CPAP is
FDA-approved for the treatment of various medical conditions, including obstructive sleep
apnea and heart failure, but is not FDA-approved for the treatment of ECAC. The study
will enroll 32 ambulatory study subjects with confirmed ECAC at the BIDMC, and each study
subject will be monitored for up to 3 months.
For info regarding 2019P001034
please contact Christine Conley at 617-632-8252 or
TSIPResearchStaff@bidmc.harvard.edu